Use of Imaging Biomarkers for Regulatory Studies
- 1 February 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Bone and Joint Surgery
- Vol. 91 (Supplement), 132-136
- https://doi.org/10.2106/jbjs.h.01545
Abstract
Imaging often plays an important role in pivotal clinical trials of drugs or devices that have been submitted for approval to regulatory agencies that grant approval for the marketing and sale of these products on the basis of documentation of their safety and efficacy. Imaging biomarkers can help substantiate either or both of these characteristics. This article focuses on how to successfully incorporate imaging biomarkers into clinical trials through a process of careful planning and diligent execution. Planning starts with posing and then answering a number of questions that pertain to the product under study. What will the claimed benefit of the product be? Is there a current standard of care that involves imaging, and will that standard of care help in the documentation of safety and efficacy? Are there relevant novel imaging biomarkers? Are there any relevant guidance documents issued by the regulatory agencies? After imaging biomarkers are identified, their role and benefit must be understood. Will they help diagnose subjects? Will they stratify subjects for enrollment? Will they identify those who are more likely to benefit? Will they help document progression of disease and effectiveness of intervention? Execution must occur in close collaboration with regulatory agencies and with the involvement of imaging experts and imaging core laboratories to ensure attention to key components: imaging charter, investigator training and certification, 21 CFR Part 11 (Part 11 of Title 21 of the U.S. Code of Federal Regulations)-compliant data management, real-time incoming image quality control for eligibility reads and investigator feedback, and centralized image analysis for safety and efficacy by certified readers.Keywords
This publication has 28 references indexed in Scilit:
- Relationship between trabecular bone structure and articular cartilage morphology and relaxation times in early OA of the knee joint using parallel MRI at 3TOsteoarthritis and Cartilage, 2008
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007
- Two year longitudinal change and test–retest-precision of knee cartilage morphology in a pilot study for the osteoarthritis initiativeOsteoarthritis and Cartilage, 2007
- Full‐limb and knee radiography assessments of varus‐valgus alignment and their relationship to osteoarthritis disease features by magnetic resonance imagingArthritis Care & Research, 2007
- Longitudinal study of magnetic resonance imaging and standard X-rays to assess disease progression in osteoarthritisOsteoarthritis and Cartilage, 2007
- Is MRI fulfilling its promise for molecular imaging of cartilage in arthritis?Osteoarthritis and Cartilage, 2006
- MRI for development of disease-modifying osteoarthritis drugsNMR in Biomedicine, 2006
- Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessmentOsteoarthritis and Cartilage, 2006
- Influence of the quality of tibial plateau alignment on the reproducibility of computer joint space measurement from Lyon schuss radiographic views of the knee in patients with knee osteoarthritisOsteoarthritis and Cartilage, 2004
- Bone Marrow Edema and Its Relation to Progression of Knee OsteoarthritisAnnals of Internal Medicine, 2003